LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $299,620 | +15.9% | 90,794 | +15.9% | 0.13% | +14.5% |
Q2 2023 | $258,558 | +52.6% | 78,351 | +53.0% | 0.12% | +67.1% |
Q1 2023 | $169,489 | -76.8% | 51,205 | 0.0% | 0.07% | -32.7% |
Q4 2022 | $732,000 | 0.0% | 51,205 | 0.0% | 0.10% | -35.4% |
Q3 2022 | $732,000 | 0.0% | 51,205 | 0.0% | 0.16% | +94.0% |
Q2 2022 | $732,000 | +52.2% | 51,205 | 0.0% | 0.08% | -25.9% |
Q1 2022 | $481,000 | +35.9% | 51,205 | 0.0% | 0.11% | +17.9% |
Q4 2021 | $354,000 | -90.9% | 51,205 | -87.4% | 0.10% | -86.9% |
Q3 2021 | $3,872,000 | -4.9% | 407,192 | 0.0% | 0.73% | +3.1% |
Q2 2021 | $4,071,000 | -14.5% | 407,192 | 0.0% | 0.70% | -18.8% |
Q1 2021 | $4,764,000 | -67.2% | 407,192 | 0.0% | 0.87% | -69.0% |
Q4 2020 | $14,540,000 | +158.4% | 407,192 | 0.0% | 2.80% | +126.9% |
Q3 2020 | $5,627,000 | -16.2% | 407,192 | 0.0% | 1.23% | -24.2% |
Q2 2020 | $6,714,000 | +94.0% | 407,192 | 0.0% | 1.63% | +78.3% |
Q1 2020 | $3,461,000 | – | 407,192 | – | 0.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |